Profitability
This table compares TSS and Pharma-Bio Serv’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
TSS | 3.59% | 87.89% | 11.84% |
Pharma-Bio Serv | -8.18% | -5.61% | -4.53% |
Valuation & Earnings
This table compares TSS and Pharma-Bio Serv”s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
TSS | $54.40 million | 5.62 | $70,000.00 | $0.18 | 71.17 |
Pharma-Bio Serv | $9.51 million | 1.40 | -$780,000.00 | ($0.03) | -19.38 |
TSS has higher revenue and earnings than Pharma-Bio Serv. Pharma-Bio Serv is trading at a lower price-to-earnings ratio than TSS, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Summary
TSS beats Pharma-Bio Serv on 9 of the 9 factors compared between the two stocks.
About TSS
TSS, Inc. offers planning, design, engineering, construction management, commissioning and maintenance services. It provides these services primarily for specialized facilities such as data centers, communications rooms, call centers, laboratories, trading floors, network operations centers, medical facilities and similar environments. TSS Inc., formerly known as Fortress International Group, Inc., is based in Columbia, United States.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.
Receive News & Ratings for TSS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TSS and related companies with MarketBeat.com's FREE daily email newsletter.